0000920465-15-000068.txt : 20150902
0000920465-15-000068.hdr.sgml : 20150902
20150902210430
ACCESSION NUMBER: 0000920465-15-000068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150831
FILED AS OF DATE: 20150902
DATE AS OF CHANGE: 20150902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 151090592
4
1
wf-form4_144124225966341.xml
FORM 4
X0306
4
2015-08-31
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
10182 TELESIS COURT, 6TH FLOOR
SAN DIEGO
CA
92121
1
1
0
0
President, CEO & Secretary
Stock Option (Right to Buy)
35.58
2015-08-31
4
A
0
40000
0
A
2025-08-31
Common Stock
40000.0
40000
D
Option vests and becomes exercisable upon the achievement of certain performance-related goals in 2016. The timing for the achievement of such goals determines the number of shares underlying the award.
Represents the maximum number of shares of common stock underlying the option grant, with the actual number of shares issuable upon exercise to be determined based on the timing of the achievement of the vesting criteria described in footnote 1.
/s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh
2015-09-02